Lin et al. later proposed a modified systemic inflammation score (mSIS) using specific LMR (3.4) and albumin (4.0 g/dL) thresholds, demonstrating its superior prognostic utility compared to the SIS in predicting OS for gastric cancer patients [15]. The gene discussed is ALB; the disease is gastric cancer.